Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Di Luccia, Blanda ^a   Crescenzo, Raffaella ^a   Mazzoli, Arianna ^a   Cigliano, Luisa ^a   Venditti, Paola ^a   Walser, Jean Claude ^b   Widmer, Alex ^b   Baccigalupi, Loredana ^a   Ricca, Ezio ^a   Iossa, Susanna ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA 16S; FRUCTOSE; ANTIINFECTIVE AGENT; FATTY ACID; GLUCOSE; GLUCOSE BLOOD LEVEL; LIPID PEROXIDE; PROTEIN KINASE B; RNA 16S;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BIOLOGICAL THERAPY; BODY COMPOSITION; CARBOHYDRATE DIET; CONTROLLED STUDY; COPROCOCCUS; DISEASE ASSOCIATION; DNA SEQUENCE; FECAL TRANSPLANTATION; FECES MICROFLORA; INFLAMMATION; INTESTINE FLORA; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; POPULATION ABUNDANCE; RAT; RAT MODEL; RUMINOCOCCUS; ANIMAL; BACTERIUM; BLOOD; CECUM; CLASSIFICATION; DIET; DISEASE MODEL; DRUG EFFECTS; FECAL MICROBIOTA TRANSPLANTATION; GENETICS; GLUCOSE BLOOD LEVEL; LIVER; METABOLISM; MICROBIOLOGY; MICROFLORA; PROCEDURES; PROTEIN CARBONYLATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BLOOD GLUCOSE; BLOTTING, WESTERN; CECUM; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FECAL MICROBIOTA TRANSPLANTATION; FRUCTOSE; GLUCOSE; LIPID PEROXIDES; LIVER; MALE; METABOLIC SYNDROME X; MICROBIOTA; MUSCLE, SKELETAL; OBESITY; PROTEIN CARBONYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S;

EID: 84941975667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134893     Document Type: Article

References (46)

1. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899-906. PMID: 17921363
2. Tappy L, Le KA, Tran C, Paquot N. Fructose and metabolic diseases: New findings, new questions, Nutrition 2010;26:1044-1049. doi: 10.1016/j.nut.2010.02.014 PMID: 20471804
3. Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obesity 2012;13:799-809.
4. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537-543. PMID: 15051594
5. Marriot BP, Cole N, Lee E. National Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States. J. Nutr. 2009;139:1228S-1235S. doi: 10.3945/jn. 108.098277 PMID: 19403716
6. Li S, Zhang HJ, Hu CC, Lawrence F, Gallagher KE, Surapaneni A, et al. Assessment of diet-induced obese rats as an obesity model by comparative functional genomics. Obesity 2008;16:811-818. doi: 10.1038/oby.2007.116 PMID: 18239588
7. Kavanagh K, Wylie AT, Tucker KL, Hamp TJ, Gharaibeth RZ, Cullen JM. Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr. 2013;98:349-357. doi: 10.3945/ajcn. 112.057331 PMID: 23783298
8. Crescenzo R, Bianco F, Falcone I, Coppola P, Liverini G, Iossa S. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr. 2013;52:537-545. doi: 10.1007/s00394-012-0356-y PMID: 22543624
9. Crescenzo R, Bianco F, Coppola P, Mazzoli A., Cigliano L., Liverini G. et al. Increased skeletal muscle mitochondrial efficiency in rats with fructose-induced alteration in glucose tolerance. Br J Nutr. 2013;110:1996-2003. doi: 10.1017/S0007114513001566 PMID: 23693085
10. Karpe F, Dickmann JR, Frayn KN. Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation. Diabetes 2011;60:2441-2449. doi: 10.2337/db11-0425 PMID: 21948998
11. McNulty NP, Wu M, Erickson AR, Pan C, Erickson BK, Martens EC, et al. Effects of diet on resource utilization by a model human gut microbiota containing bacteroides cellulosilyticus WH2, a symbiont with an extensive glycobiome. PLoS Biol. 2013;11:e1001637. doi: 10.1371/journal.pbio.1001637 PMID: 23976882
12. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Turnbaugh PJ et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-563. doi: 10.1038/nature12820 PMID: 24336217
13. Daniel H, Moghaddas Gholami A, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J. 2014;8:295-308. doi: 10.1038/ismej.2013.155 PMID: 24030595
14. Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterol. 2009;136:1476-1483.
15. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011;333:101-104. doi: 10.1126/science.1206025 PMID: 21596954
16. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011;5:220-230. doi: 10.1038/ismej. 2010.118 PMID: 20686513
17. Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab. 2013;10:35. doi: 10.1186/1743-7075-10-35
18. Buettner R, Schölmerich J, Bollheime LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007;15:798-808. PMID: 17426312
19. Crescenzo R, Bianco F, Coppola P, Mazzoli A, Valiante S., Liverini G, et al. Adipose tissue remodeling in rats exhibiting fructose-induced obesity. Eur J Nutr. 2014;53:413-419. doi: 10.1007/s00394-013-0538-2 PMID: 23728711
20. Ferrier L, Berard F, Debrauwer L, Chabo C, Langella P, Bueno L, et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol. 2006;168:1148-1154. PMID: 16565490
21. Folch J, Lees M, Stanley GHS A. simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-510. PMID: 13428781
22. Crescenzo R, Bianco F, Falcone I, Prisco M, Liverini G, Iossa S. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity 2008;16:958-964. doi: 10.1038/oby.2008.10 PMID: 18277391
23. Heath RL, Tappel AL. A new sensitive assay for the measurement of hydroperoxides. Anal Biochem. 1976;76:184-191. PMID: 998964
24. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth Enzymol. 1994;233:357-363. PMID: 8015470
25. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci. USA 2010;108:4516-4522. doi: 10.1073/pnas.1000080107 PMID: 20534432
26. Wang Y, Qian PY. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 2009;4(10):e7401. doi: 10.1371/journal. pone.0007401 PMID: 19816594
27. Magoc T, Salzberg S. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011;27:2957-2963. doi: 10.1093/bioinformatics/btr507 PMID: 21903629
28. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Meth. 2010;7(5):335-366.
29. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26(19):2460-2461. doi: 10.1093/bioinformatics/btq461 PMID: 20709691
30. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl EnvironMicrobiol. 2007;73(16):5261-5267. PMID: 17586664
31. Caporaso JG, Bittinger K, Bushman FD, De Santis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010;26(2):266-267. doi: 10.1093/bioinformatics/btp636 PMID: 19914921
32. De Santis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069-5072. PMID: 16820507
33. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One 2010;5(3):e9490. doi: 10.1371/journal.pone.0009490 PMID: 20224823
34. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228-8235. PMID: 16332807
35. Piya MK, Harte AL, McTernan PG. Metabolic endotoxaemia: is it more than just a gut feeling? Curr Opin Lipidol. 2013;24:78-85. doi: 10.1097/MOL.0b013e32835b4431 PMID: 23298961
36. Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M, et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res. 2010;20:1411-1419 doi: 10.1101/gr. 107987.110 PMID: 20736229
37. Van De Woestijne P, Monajemi H, Kalkhoven E, Visseren FLJ. Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev. 2011;12:829-840. doi: 10.1111/j.1467-789X.2011.00900.x PMID: 21749607
38. Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, et al. Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol. 2008;48:983-992. doi: 10.1016/j.jhep. 2008.01.035 PMID: 18395289
39. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008;22:2416-2426. doi: 10.1096/fj.07-102723 PMID: 18326786
40. Carvalho BM, Guadagnini D, Tsukumo DML, Schenka AA, Latuf-Filho P, Vassallo J, et al. Modulation of gut microbiota by antibiotics improves insulin signaling in high-fat fed mice. Diabetologia 2012;55:2823-2834. doi: 10.1007/s00125-012-2648-4 PMID: 22828956
41. Johnson RJ, Rivard C, Lanaspa MA, Otabachian-Smith S, Ishimoto T, Cicerchi C, et al. Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection? J Equine Vet Sci. 2013;33:120-126. PMID: 23439477
42. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterol. 2012;143:913-916.
43. Stump CS, Henriksen EJ, Wei Y, Sowers JR. The metabolic syndrome: role of skeletal muscle metabolism. Ann Med. 2006;38:389-402. PMID: 17008303
44. Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One 2013;8(5):e63983. doi: 10.1371/journal.pone. 0063983 PMID: 23704966
45. Nishio K, Horie M, Akazawa Y, Shichiri M, Iwahashi H, Hagihara Y, et al. Attenuation of lipopolysaccharide (LPS)-induced cytotoxicity by tocopherols and tocotrienols. Redox Biol. 2013;1(1):97-103.
46. Hakansson A. and Molin G. Gut Microbiota and Inflammation. Nutrients 2011;3:637-682. doi: 10.3390/nu3060637 PMID: 22254115